Categorized | All Episodes

September 27, 2012: The Future of Generic Biotech Crops

Senior Fellow Greg Conko discusses his new paper, “Is There a Future for Generic Biotech Crops? Regulatory Reform Is Needed for a Viable Post-Patent Industry.” Patents will soon expire for several popular biotech crops, opening the way for cheaper generic versions. But because, unlike prescription drugs, biotech crops have to be re-approved every few years, the future of generic biotech crops is very much in doubt. Conko recommends getting rid of re-approval requirements to put them on the same footing as other products.

One Response to “September 27, 2012: The Future of Generic Biotech Crops”

Trackbacks/Pingbacks


Subscribe

  • Subscribe with iTunes
  • Podcast Feed

More Info

Give Us Feedback

Send us your comments:
feedback@libertyweek.org